Seiji Hishida   Kyojiro Kawakami   Yasunori Fujita   Taku Kato   Manabu Takai   Koji Iinuma   Keita Nakane   Tomohiro Tsuchiya   Takuya Koie   Yuri Miura   Masafumi Ito   Kosuke Mizutani   
The Prostate 81(9) 592-602 2021年6月 [査読有り]
BACKGROUND: Cabazitaxel (CBZ) is now widely used for prostate cancer (PC) patients resistant to docetaxel (DOC), however, most patients eventually acquire resistance. It will, therefore, be of great benefit to discover novel therapeutic target for...